Trial Search Results

Zemedy Application for Irritable Bowel Syndrome

The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: Bold Health Inc.

Stanford Investigator(s):


  • Device: Use of Zemedy Application




Inclusion Criteria:

   1. Male and female patients >=18 years old.

   2. Meet Rome IV criteria for IBS for at least 6 months. No restrictions on type of IBS.

   3. English proficiency (in order to understand use of the application.

   4. Patient must be on a stable regimen for IBS for at least 30 days.

   5. Patients must own a smartphone (iOS or Android) in order to participate in the CBT

Exclusion Criteria:

   1. Laboratory or imaging evidence of an alternative explanation of patient's symptoms.

   2. Active gastrointestinal disease such as Crohn's disease, ulcerative colitis, history
   of complete colon resection, acute infection, or any disease that precludes
   participation in CBT application.

   3. Patient already undergoing cognitive behavioral therapy.

   4. Severe anxiety or depression assessed by the HADS scale.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Brandon Lam, BS